CC2D1B: A Potential Drug Target and Biomarker (G200014)

Target Name: CC2D1B

NCBI ID: G200014

CC2D1B

CC2D1B: A Potential Drug Target and Biomarker

Giant discs homolog 1 (CC2D1B) is a gene that encodes a protein located in the cytosol of eukaryotic cells. The cytosol is the fluid inside cells that contains various organelles and other cellular components. The cytosol is also the site of many cellular processes, including the transport of drugs and other molecules across cell membranes. As a result, CC2D1B is a potential drug target or biomarker that could be targeted by small molecules or other therapeutic agents to modulate cellular processes and therapeutic outcomes.

Disease and Therapeutic Applications

CC2D1B is involved in a variety of cellular processes that are important for normal cellular function and development. One of its functions is to help regulate the movement of cells and organelles within the cytosol. This is important for maintaining the proper structure and function of cells and is critical for cellular processes such as cell division, migration, and the transport of nutrients and waste products.

In addition to its role in cytosolic transport, CC2D1B is also involved in the regulation of cell signaling pathways. It has been shown to play a role in the regulation of mitochondrial function and in the detoxification of harmful substances. It is also involved in the regulation of the production of various signaling molecules, including mitochondrial proton motive force (MPF) channels.

As a potential drug target, CC2D1B is of interest because it is involved in the regulation of cellular processes that are often disrupted in diseases such as cancer, neurodegenerative diseases, and cardiovascular disease. For example, studies have shown that CC2D1B is often expressed at higher levels in cancer cells than in normal cells, and that inhibiting its activity has been shown to be a potential therapeutic approach for cancer treatment.

Another potential application of CC2D1B as a drug target is its role in the regulation of neurodegenerative diseases. Many neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles. It is thought that the dysfunction in neurodegenerative diseases is caused by the misfolding and misregulation of various signaling proteins, including CC2D1B.

In addition to its potential therapeutic applications, CC2D1B is also of interest as a biomarker for disease diagnosis and monitoring. The misfolding and misregulation of proteins, including CC2D1B, have been implicated in a variety of diseases, including cancer, neurodegenerative diseases, and cardiovascular disease. Therefore, measuring the levels of CC2D1B in cells or tissues could be a potential diagnostic or monitoring tool for these diseases.

An Overview of CC2D1B

CC2D1B is a gene that encodes a protein located in the cytosol of eukaryotic cells. The cytosol is the fluid inside cells that contains various organelles and other cellular components. The cytosol is also the site of many cellular processes, including the transport of drugs and other molecules across cell membranes.

The CC2D1B protein is a member of the superfamily of cytosolic proteins known as the transport proteins. These proteins are involved in the transport of various molecules across cell membranes, including small molecules, ions, and proteins. The CC2D1B protein is thought to have a unique structure that allows it to transport molecules across cell membranes in a specific way.

In addition to its role in cytosolic transport, CC2D1B is also involved in the regulation of cell signaling pathways. It has been shown to play a role in the regulation of mitochondrial function and in the detoxification of

Protein Name: Coiled-coil And C2 Domain Containing 1B

Functions: Transcription factor that binds specifically to the DRE (dual repressor element) and represses HTR1A gene transcription in neuronal cells

The "CC2D1B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CC2D1B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets